2 terminated, 1 completed, 1 recruiting. 4 Phase 2, 3 Phase 1, 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 4 | Terminated 2, Completed 1, Recruiting 1 |
| Phase 1 | 3 | Terminated 2, Recruiting 1 |
| Phase 3 | 1 | Completed 1 |
Follow Nanobiotix: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| NBTXR3 With Radiation Therapy Alone for Locally-advanced Non-small Cell Lung Cancer NBTXR3 - Locally-Advanced Non-Small Cell Lung Cancer | Phase 1 / Phase 2 | Recruiting | M.D. Anderson Cancer Center | 40 | 2026-03-27 | 2026-09-18 |
| NBTXR3 Nanoparticles and EBRT or EBRT With Brachytherapy in the Treatment of Prostate Adenocarcinoma NBTXR3 activated by IMRT only, NBTXR3 activated by Brachytherapy & IMRT - Prostate Cancer | Phase 1 / Phase 2 | Terminated | Nanobiotix | 5 | 2017-11-15 | 2021-05-10 |
| NBTXR3 Crystalline Nanoparticles and Stereotactic Body Radiation Therapy in the Treatment of Liver Cancers NBTXR3, IL or IA injection + SBRT - Liver Cancer | Phase 1 / Phase 2 | Terminated | Nanobiotix | 23 | 2016-01-28 | 2021-05-10 |
| NBTXR3 Crystalline Nanoparticles and Radiation Therapy in Treating Randomized Patients in Two Arms With Soft Tissue Sarcoma of the Extremity and Trunk Wall NBTXR3, Radiation therapy - Adult Soft Tissue Sarcoma | Phase 2 / Phase 3 | Completed | Nanobiotix | 180 | 2015-03-03 | 2021-04-06 |
Liver Neoplasms (1) · Prostatic Neoplasms (1) · Sarcoma (1)
Radiosurgery (1) · Radiotherapy (1) · Radiotherapy, Intensity-Modulated (1)
France (2) · United States (2) · Australia (1) · Belgium (1) · Germany (1) · Hong Kong (1) · Hungary (1) · Italy (1) · Norway (1) · Philippines (1) · Poland (1) · Romania (1) · South Africa (1) · Spain (1)
Adam Dicker, MD (1) · Aileen Chen, MD (1)